ANGPT2 and idiopathic pulmonary arterial hypertension: However, additional information has emerged more recently, suggesting that ANG2 is not associated with treatment response in patients with IPAH [89], although it may be used as a diagnostic and prognostic marker in Group 3 patients with PH.